These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21216831)

  • 41. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.
    Riegger GA; Elsner D; Kromer EP; Daffner C; Forssmann WG; Muders F; Pascher EW; Kochsiek K
    Circulation; 1988 Feb; 77(2):398-406. PubMed ID: 2962788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Localization of corin and atrial natriuretic peptide expression in human renal segments.
    Dong L; Wang H; Dong N; Zhang C; Xue B; Wu Q
    Clin Sci (Lond); 2016 Sep; 130(18):1655-64. PubMed ID: 27343265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.
    van den Berg MP; Tjeerdsma G; Jan de Kam P; Boomsma F; Crijns HJ; van Veldhuisen DJ
    Eur J Heart Fail; 2002 Jun; 4(3):255-62. PubMed ID: 12034149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.
    Shimamoto K; Kusumoto M; Sakai R; Watanabe H; Ihara S; Koike N; Kawana M
    Can J Cardiol; 2007 Mar; 23(4):295-300. PubMed ID: 17380223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt.
    Willenbrock R; Scheuermann M; Thibault G; Haass M; Höhnel K; Bohlender J; Luft FC; Dietz R
    Cardiovasc Res; 1999 Jun; 42(3):733-42. PubMed ID: 10533614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased plasma cyclic guanosine monophosphate concentrations in children with high levels of circulating atrial natriuretic peptide.
    Weil J; Gerzer R; Strom T; Lang RE; Döhlemann C; Knorr D; Bidlingmaier F
    Pediatrics; 1987 Oct; 80(4):545-8. PubMed ID: 2821478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.
    Friedl W; Mair J; Thomas S; Pichler M; Puschendorf B
    Heart; 1996 Aug; 76(2):129-36. PubMed ID: 8795474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
    Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
    Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
    J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased plasma levels of adrenomedullin in patients with heart failure.
    Nishikimi T; Saito Y; Kitamura K; Ishimitsu T; Eto T; Kangawa K; Matsuo H; Omae T; Matsuoka H
    J Am Coll Cardiol; 1995 Nov; 26(6):1424-31. PubMed ID: 7594065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    Baris Feldman H; Chai Gadot C; Zahler D; Mory A; Aviram G; Elhanan E; Shefer G; Goldiner I; Amir Y; Kurolap A; Ablin JN
    N Engl J Med; 2023 Nov; 389(18):1685-1692. PubMed ID: 37913506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corin-mediated processing of pro-atrial natriuretic peptide in human small cell lung cancer cells.
    Wu F; Wu Q
    Cancer Res; 2003 Dec; 63(23):8318-22. PubMed ID: 14678991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypertension in mice lacking the proatrial natriuretic peptide convertase corin.
    Chan JC; Knudson O; Wu F; Morser J; Dole WP; Wu Q
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):785-90. PubMed ID: 15637153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men.
    Hunt PJ; Espiner EA; Richards AM; Yandle TG; Frampton C; Nicholls MG
    Am J Physiol; 1995 Dec; 269(6 Pt 2):R1397-403. PubMed ID: 8594942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between atrial natriuretic peptide and cyclic GMP in hypertension and in chronic renal failure.
    Sagnella GA; Saggar-Malik AK; Buckley MG; Markandu ND; Eastwood JB; MacGregor GA
    Clin Chim Acta; 1998 Jul; 275(1):9-18. PubMed ID: 9706839
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
    Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Longitudinal changes in maternal corin and mid-regional proatrial natriuretic peptide in women at risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Elkhouli M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Feb; 45(2):190-8. PubMed ID: 25296530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atrial natriuretic peptide (ANP) as an endogenous anxiolytic in patients with heart failure? - No replication of previous results showing an inverse association of anxiety and plasma ANP parameters.
    Kellner M; Yassouridis A; Waheed S; Górski D; Kähler J; Wiedemann K
    J Psychosom Res; 2021 Sep; 148():110560. PubMed ID: 34230001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.